EOS, Tecomet, Orthopaedic Innovation Centre (OIC) and Precision ADM announced a new additive manufacturing partnership.
The partnership aims to offer an end-to-end solution for medical device additive manufacturing. It includes a full range of services, such as front-end engineering and design services and FDA 510(k) approval pathways. The companies also plan to offer device and machine validation, pre-clinical testing and commercialization services.
According to the companies, the complete solution the partnership allows for a significant reduction in product development lead time for medical OEMs. It could also reduce time to market and overall risk while leveraging the innovations of additive manufacturing, or 3D printing.
Each company in the partnership offers strengths and industry knowledge to deliver a seamless, turnkey solution for medical device 3D printing. EOS offers both metal and polymer additive manufacturing while Tecomet specializes in manufacturing medical devices and components. OIC provides accredited medical device testing and contract clinical research services. Precision ADM offers comprehensive engineering and additive manufacturing services to the medical device industry.
“Scaling AM medical device production requires a complete understanding of the process chain, which goes beyond just printing and includes design, post-processing, testing, sterilization, and packaging, among other steps,” said Dr. Gregory Hayes, EOS SVP of applied engineering. “Our partnership with Tecomet, OIC and Precision ADM will yield unparalleled additive manufacturing expertise to help medical device manufacturers navigate the complexities of the regulatory environment while delivering high-quality, reliable products.”
